CRCA vs. TPYP
CRCA (ProShares Ultra CRCL) and TPYP (Tortoise North American Pipeline Fund) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while TPYP is a Energy Equities fund tracking the Tortoise North American Pipeline Index. CRCA is actively managed, while TPYP is passively managed. At a correlation of -0.05, they often move in opposite directions. CRCA charges 0.95%/yr vs 0.40%/yr for TPYP.
Performance
CRCA vs. TPYP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -71.04% return, which is significantly lower than TPYP's 25.73% return.
CRCA
- 1D
- -0.69%
- 1M
- -49.35%
- 6M
- -69.61%
- YTD
- -71.04%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TPYP
- 1D
- 0.23%
- 1M
- 6.20%
- 6M
- 22.68%
- YTD
- 25.73%
- 1Y
- 29.16%
- 3Y*
- 25.62%
- 5Y*
- 19.98%
- 10Y*
- 11.76%
CRCA vs. TPYP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -71.04% | -84.67% |
TPYP Tortoise North American Pipeline Fund | 25.73% | 2.15% |
Correlation
The correlation between CRCA and TPYP is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | -0.05 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. TPYP — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
TPYP
CRCA vs. TPYP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Tortoise North American Pipeline Fund (TPYP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | TPYP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.36 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 4.28 | — |
| Martin ratioReturn relative to average drawdown | — | 10.23 | — |
Loading charts...
Drawdowns
CRCA vs. TPYP - Drawdown Comparison
The maximum CRCA drawdown since its inception was -95.56%, which is greater than TPYP's maximum drawdown of -51.91%. Use the drawdown chart below to compare losses from any high point for CRCA and TPYP.
Loading charts...
Drawdown Indicators
| CRCA | TPYP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.56% | -51.91% | -43.65% |
Max Drawdown (1Y)Largest decline over 1 year | — | -6.84% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -13.17% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -17.96% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -51.91% | — |
Current DrawdownCurrent decline from peak | -95.56% | -0.80% | -94.76% |
Average DrawdownAverage peak-to-trough decline | -73.37% | -7.85% | -65.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.86% | — |
Volatility
CRCA vs. TPYP - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | TPYP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 5.01% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 10.87% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 194.44% | 13.72% | +180.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 194.44% | 17.43% | +177.01% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 194.44% | 21.89% | +172.55% |
CRCA vs. TPYP - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than TPYP's 0.40% expense ratio.
Dividends
CRCA vs. TPYP - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 7.61%, more than TPYP's 3.14% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 7.61% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TPYP Tortoise North American Pipeline Fund | 3.14% | 3.91% | 3.95% | 4.83% | 4.48% | 4.86% | 6.14% | 4.45% | 4.58% | 3.71% | 3.49% | 2.56% |
Frequently Asked Questions
CRCA and TPYP have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, TPYP is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TPYP is cheaper with a 0.40% expense ratio, compared with 0.95% for CRCA.
CRCA has the higher dividend yield at 7.61%, compared with 3.14% for TPYP.
CRCA is categorized as Leveraged Equities, while TPYP is Energy Equities. They also come from different issuers: ProShares and Tortoise. Their fees differ too: 0.95% for CRCA and 0.40% for TPYP.
Find the right allocation for CRCA and TPYP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer